M&A Deal Summary |
|
|---|---|
| Date | 2022-09-27 |
| Target | Western Star Concrete |
| Sector | Construction |
| Buyer(s) | Endonovo Therapeutics |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2008 |
| Sector | Life Science |
Endonovo Therapeutics is a biotechnology company developing off-the-shelf, cell-free regenerative products and non-invasive, bioelectronic therapies designed to extend and enhance human life by regenerating tissues and organs that have become injured or damaged due to disease and age. Endonovo Therapeutics was founded in 2008 and is headquartered in Woodland Hills, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Construction M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Texas M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2022 M&A | 1 of 1 |
